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Abstract: The 2011 American Academy of Pediatrics (AAP) Urinary Tract Infection (UTI):Clinical Practice Guideline 
for the Diagnosis and Management of the Initial UTI in Febrile Infants and Children 2-24 Months guideline addressed 
“areas for research” identifying multiple areas where evidence at the time of the publication was lacking. This review 
discussed the evidence development in those identified areas. In this paper, I will review the latest literature on UTI in 
children and focus on those areas of research suggested in these guidelines. I will also summarize the related literature 
since September 2011. 
Literature related to first UTI in children have contributed important new knowledge since the publication of the 2011 
AAP guideline; 1) additional research has failed to clarify the relationship between childhood UTI and adult renal 
function. 2) High grade vesicoureteral reflux (VUR) has been established as a clear risk factor for scarring, but the 
condition is rare. Abnormal ultrasound, and fever in combination with non-E coli infection are other important predictors 
of scarring. 3) Antimicrobial prophylaxis appear to decrease UTI recurrences, but a large amount of antibiotics has to be 
administrated to prevent one UTI and the prevention works best in children with low grade, not high grade, VUR, 4) 
cranberry juice may prevent UTI, and 5) new, less aggressive guidelines, seem not to have negative consequences for 
pediatric patients measured as missed true pathology. Future guidelines would benefit from incorporating this new 
information. 
Keywords: Chronic kidney disease, cystourethrogram, renal and bladder ultrasound, Urinary tract infection, renal scarring, 
voiding. 
INTRODUCTION 
 UTI is a common cause of illness in children, with a 
prevalence of approximately 5% among children 2-24 
months of age with fever without obvious source [1]. As the 
presentation of UTI in young children are often nonspecific, 
and reliable urine specimens for culture require invasive 
methods, the diagnosis may be clinically challenging. With 
the goal of guiding clinicians and avoiding delays in 
diagnosis and treatment, multiple guidelines from numerous 
sources have been published over the last few years [1-4]. 
 In 2011, the Subcommittee on Urinary Tract Infection, 
American Academy of Pediatrics (AAP) published the 
Clinical Practice Guideline for the Initial UTI in Febrile 
Infants and in Children of 2-24 Months [1]. The guideline is 
a revision of the 1999 practice parameter [5] on the same 
topic and presents seven action statements addressing 
recommendations for diagnosis, management, and follow up 
of UTI in young children. The publication is also 
accompanied by a technical report outlining the current 
evidence for listed action statements [6]. The most 
controversial change in the recommendations was to 
recommend a renal and bladder ultrasound (RBUS) for all 
children after the first UTI, but no longer routinely 
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recommend a voiding cystourethrogram (VCUG). This 
change has spurred plenty of debate in the medical 
community [7-9]. 
 In addition to providing updated recommendations and 
the evidence for those, the 2011 AAP guideline also 
addressed “areas for research”, identifying multiple areas 
where evidence at the time was lacking. What follows in this 
review is the evidence development that has occurred in 
those identified areas. 
CHILDHOOD UTI AND RISK OF ADULT RENAL 
FAILURE 
 The link between childhood UTIs and the consequences 
for adult renal function had not been well established in 
2011. Retrospective studies had addressed selected 
populations [6]. Ecological data from Australia [10] had 
demonstrated no changes in the rates of hypertension and 
renal failure since the widespread introduction of 
antimicrobial prophylaxis. A prospective cohort of children 
from birth until late middle age is still missing, but several 
recent publications have added some additional evidences in 
this area. In 2011, Salo et al. [11] published a study on the 
association between childhood UTI and chronic kidney 
disease (CKD). First, the authors conducted a literature 
search from 1966-2009 followed by a systematic review. 
Among the 1576 patients included, none had childhood UTI 
as the main cause of subsequent CKD. Secondly, they 
reviewed records of 366 patients treated or monitored for 
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CKD at the Oulu University Hospital, Finland. Of the 58 
patients without a specific noninfectious cause of CKD, one 
had recurrent UTI in childhood as a possible cause of CHD. 
The authors concluded that the etiological fraction of 
childhood UTI as main cause of CKD seems to be low. 
 In 2011, Round et al. [12] also published an article 
aiming to determine the true level of risk that a female child 
with first-time UTI will subsequently develop an end stage 
renal disease (ESRD) attributable to UTI. Data was collected 
from five renal registries around the world. Five different 
models were tested and the risk ranged from 1/154 - 
1/114,943. The authors conclude that there is considerable 
uncertainty in the relationship between childhood UTI and 
the risk of ESRD. 
 Lastly, Toffolo et al. [13] published an additional 
systematic review in 2012. The authors reviewed 20 cohorts 
(3573 children) from 23 papers published 1980-2011 to 
determine the relationship between UTIs and blood pressure, 
renal function, growth and pregnancy-related complications. 
The authors concluded that there are not any clear data 
regarding long-term consequences following UTIs in 
childhood. Most data however, indicate that the outcome of 
renal function can be predicted, based on renal function at 
first and then follow up or during the first few visits. Only 
0.4% of children with normal renal function initially 
presented with decreased renal function at follow up. 
 To summarise the additional data published fail to detect 
a strong relationship between childhood UTI and decreased 
renal function in adults. 
RISK FACTORS FOR RENAL SCARRING 
 Renal scarring is known to occur both, in the presence 
and absence of VUR, but the degree of importance of VUR 
as a predictor of scarring was not well understood in 2011. 
 Since then, Snodgrass et al. [14] published a cross-
sectional observational study of 565 patients referred for 
urological assessment of febrile UTI and/or VUR. Most 
patients (80%) had no evidence of renal damage determined 
by dimercaptosuccinic acid (DMSA) scintigraphy. All grades 
of VUR however, increased risk for focal cortical defects 
versus no VUR. Grades IV and V VUR had much greater 
likelihood of scarring as compared to patients with grade I-
III VUR. 
 An additional important paper on this topic was 
published in 2014 by Shaikh et al. [15]. The authors 
examined the association of predictor variables assessed at 
the time of a first UTI and the development of renal scarring. 
Studies with positive findings of a urine culture, defined by 
the recovery of any organisms from a suprapublic specimen, 
more than 10,000 colony-forming units /mL from catheter-
collected specimen, and more than 100,000 colony-forming 
units/mL from a clean-voided or a bag specimen, were 
included. Aiming to a non biased result, studies focused only 
on highly selected subgroups of children with UTI were 
excluded, including studies of only neonates. The authors 
searched MEDLINE and EMBASE and identified 23 studies 
meeting inclusion criteria. For 9/23 studies the original 
authors, and if necessary co-authors, responded to e-mail 
requests for individual level data. The authors then pooled 
this information for children between the age of 0-18 years. 
The obtained data was used in a prediction model including 
age, sex, measured temperature at the time of diagnosis, 
duration of fever before presentation, grade of VUR, the 
organism isolated from culture (Escherichia coli vs other), 
results of RBUS (normal vs abnormal), and inflammatory 
markers (C-reactive protein and poly morphonuclear cells, 
erythrocyte sedimentation rate, procalcitonin). Data on the 
year of enrollment as well as method of urine collection (bag 
vs no bag) were also gathered. The primary outcome in the 
article were presence of scarring, defined as any photopenia 
on a scan obtained at least 5 months after the initial UTI. 
Univariate and multivariate analysis were used in the 
development of the predictor model. 
 In the end, 1280 children were included in the analysis. 
64.2% were girls and 83.7% were younger than 24 months. 
Renal scarring was present in 199 (15.5%) of children. The 
risk factors associated with renal scarring were grade IV or 
V VUR, abnormal RBUS finding, grade III VUR, C-reactive 
protein of more than 40mg/L, temperature of at least 39° C, 
organism other than E coli, polymorphonuclear cell count of 
more than 60% and grade I and II VUR, listed from most to 
least important. Age, sex and duration of fever before 
presentation were however not associated with renal 
scarring. The authors pointed out that grade IV and V VUR 
were by far the most important risk factors for renal scarring 
but they were found only in 4.1% of the children overall. 
Children with low grade VUR (grade I and II) had odds of 
scarring similar to those without VUR. The authors 
concluded that children with an abnormal RBUS result, or 
with a combination of high fever and a culture organism 
other than E coli are at a high risk of developing renal 
scarring. 
THE EFFECTIVENESS OF ANTIBIOTIC PROPHYLAXIS 
 As previously mentioned, the most controversial 
recommendation in the 2011 AAP guideline was action 
statement 6a, “VCUG should not be performed routinely 
after the first febrile UTI; VCUG is indicated if RBUS 
reveals hydronephrosis, scarring, or other findings that 
would suggest either high-grade VUR or obstructive 
uropathy, as well as in other atypical or complex clinical 
circumstances” [1]. The 1999 version of the guideline had 
assumed a 100% effectiveness from antimicrobial 
prophylaxis in preventing recurrent UTI, but as the evidence 
for the 2011 revision was collected, it became clear that this 
assumption was incorrect. Data from eight randomized 
controlled trials examining the effect of antimicrobial 
prophylaxis in children with UTI were collected. Meta-
analysis failed to detect a significant difference in recurrence 
of pyelonephritis both in analysis of all children (age 0-18 
years) as well as in children of 2-24 months of age [6]. 
Surprisingly, the point estimated suggested greater effect 
from antimicrobial prophylaxis in children without VUR, 
than in children with VUR. The rationale for routine VCUG 
was thus questioned, leading to the revised recommendation. 
In 2014  the results from the long awaited RIVUR [16] trial 
was published. RIVUR is a United States 2-year, 
multicenter, randomized, placebo-controlled trial involving 
607 children with VUR who were diagnosed after a first or 
second febrile or symptomatic UTI. Primary outcome was 
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the efficacy of trimethoprim-sulfamethoxazole in preventing 
recurrent UTI. Secondary outcomes were renal scarring, 
treatment failure (a composite of recurrences and scarring), 
and antimicrobial resistance. The included children were 
mostly commercially insured white female recruited after a 
first UTI, and ranged from 2-72 months of age, with a 
median age of 12 months. Adherence was measured by self-
report and was high. As many as 76.9% of participants 
reported to have taken the medication at least 75% of the 
time. 
 Recurrent UTI was developed in 39 of 302 (12.8%) 
children who received prophylaxis as compared with 72 of 
305 (25.4%) children who received placebo. The relative risk 
was 0.55, 95% CI 0.38-0.78. The absolute risk reduction was 
12.6%. Eight children would have to be treated for 2 years 
with 5840 doses of antibiotics to prevent one case of febrile 
or symptomatic urinary tract infection. The hazard ratio was 
lower, indicating a better effect in children with low grade 
VUR versus those with high grade VUR. Outcome scans 
showed no significance between group differences in the 
incidence of renal scarring, 11.9% in the prophylaxis group 
and 10.2% in the placebo group. Significantly more children 
in the prophylaxis group presented with a trimethoprim-
sulfamethoxazole resistant E coli infection than those in the 
placebo group, 63% vs 19%. In summary, the RIVUR trial 
provided important additional data on the effect of 
antimicrobial prophylaxis in preventing recurrent UTI. In 
this trial, the risk of recurrence was reduced by 50%. 
However, a substantial amount of antibiotics have to be 
prescribed to prevent one recurrent infection, and the 
medicine works less well in children with high grade VUR. 
Scarring was not impacted. 
ALTERNATIVE TO ANTIBIOTIC PROPHYLAXIS 
 Other treatments have been suggested as a desirable 
alternative in preventing recurrent UTI. At least two 
additional randomized controlled trials on the effect of 
cranberry used as such an alternative have been published 
since 2011. Salo et al. [11] randomized 263 Finnish children 
to cranberry juice for 6 months. There were no statistical 
difference in overall risk of recurrence between the two 
groups, 16% in cranberry group and 22% in placebo group, 
but children in the cranberry group had fewer recurrences. 
Furthermore, Afshar et al. [17] randomized 40 children to 
daily cranberry juice with and without proanthocyanidin and 
concluded that the children receiving cranberry juice with 
proanthocyanidin had a 65% reduction in UTI recurrences. 
OTHER AREAS IDENTIFIED AS LACKING 
EVIDENCE 
 Beyond those areas addressed in this review, several 
additional areas for research were identified in the 2011 AAP 
guideline. Unfortunately, little additional data have been 
published on alternative techniques allowing less invasive 
sampling of urine, racial and genetic differences in risk of 
UTI and recurrence, or on optimal duration of antibiotic 
treatment. Such publications may of course be under review. 
 
IMPACT ON CHANGING IMAGING GUIDELINES 
 Lastly, a growing body of evidence is being generated to 
assess the impact of the recently recommended more 
conservative approach regarding imaging after a first UTI. In 
2011, Deader et al. [18] assessed the impact of the 2007 
NICE guideline, which recommends no routine imaging, 
including no RBUS. The authors retrospectively reviewed 
346 RBUS results. Scans were categorized dependent on 
whether it was appropriately or inappropriately to have been 
performed under the new NICE guidelines and by normal or 
abnormal RBUS result. In children 0-3 years of age only 1 of 
the 95 children was judged to have benefited from an initial 
RBUS scan which he/she would not receive under the NICE 
guideline. The 2011 AAP guideline does however 
recommend routine RBUS, but no routine of VCUG. That 
approach is supported by the Shaikh et al. [15] article where 
RBUS appeared as the most valuable test to predict which 
infants and young children will incur in renal scarring. Such 
an approach is also supported by the results in an article by 
Hannula et al. from 2011 [19]. The authors reviewed data on 
1185 children who had undergone both RBUS and VCUG. 
They determined the total number of possibly missed 
pathological finding to 4.9% if VCUG were not performed. 
However, the majority of these findings had no long-term 
consequences and the authors concluded that children with 
UTI should be examined with RBUS alone and that VCUG 
should be performed “only after additional circumstances”. 
In 2012 Pennesi et al. [20] further added to this body of 
work. Retrospective review of 406 children aged 1-36 
months at their first UTI was performed to assess the revised 
Italian guideline. All patients underwent RBUS; those with 
abnormal RBUS and those with recurrence underwent both 
VCUG as well as DMSA scan. RBUS was pathological in 
7.4% of children. Of the 48 VCUG performed, 14 showed 
VUR. Of the 14 children with VUR, 12 had abnormal 
ultrasound and 2 had recurrent UTI (which would have 
resulted in a VCUG even under the new guidelines). 
Scarring was detected in 6 children all of whom had grade 
IV VUR. The authors concluded that the revised guidelines 
for children with first UTI would result in a decrease in 
invasive examinations without compromising child health. 
 Lastly, La Scola et al. [21] evaluated the yield, economic, 
and radiation costs of five guideline algorithms (Melbourne 
Royal Children’s Hospital, National Institute of Clinical 
Excellence-NICE), the “top down approach”, AAP, and 
Italian Society of Pediatric Nephrology compared to a 
protocol where all the tests are done. Primary outcomes were 
the yield of abnormal tests, secondary outcomes were 
economic and radiation costs. 304 children were eligible. 
The top down approach showed the highest sensitivity for 
detection of VUR as well as scars (76% and 100% 
respectively), but was also the most costly. NICE and AAP 
were most specific for VUR, and the Italian Society of 
Pediatric Nephrology was most specific for scars. NICE 
would have been the least costly approach and AAP would 
have resulted in the least radiation. Authors concluded that 
an aggressive protocol has a high sensitivity for detecting 
VUR and scarring, but carries financial and radiation costs 
without proven benefit. 
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CONCLUSION 
 Literature related to first UTI in children have 
contributed important new knowledge since the publication 
of the 2011 AAP guideline; 1) additional research has failed 
to clarify the relationship between childhood UTI and adult 
renal function. 2) High grade VUR has been established as a 
clear risk factor for scarring, but the condition is rare and 
abnormal ultrasound, or fever in combination with non-E 
coli infection are other important predictors of scarring. 3) 
Antimicrobial prophylaxis appear to decrease UTI 
recurrences, but large amounts of antibiotics have to be 
administrated to prevent one UTI and the prevention works 
best in children with low grade VUR. 4) Cranberry juice may 
prevent UTI, and 5) new, less aggressive guidelines, seem 
not to have negative consequences for pediatric patients 
measured as missed true pathology. Future guidelines would 
benefit from incorporating this new information. 
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